Noteworthy News

[brewer]

https://covid19criticalcare.com/wp-conte...VID-19.pdf

That's not a study. Don't be intentionally dense to try and support a position.

And that linked paper has been rejected:

The editors of Frontiers in Pharmacology have taken down an article about the use of the antiparasitic drug ivermectin in COVID-19 patients. The paper, which was written by members of an organization called the Front Line COVID-19 Critical Care Alliance (FLCCC), had been provisionally accepted and posted in abstract form by the journal in January, but was ultimately rejected this Monday (March 1). The editors determined that it contained unsubstantiated claims and violated the journal’s editorial policies.

https://www.the-scientist.com/news-opini...tion-68505

“Regardless of the publication stage or subject of a manuscript, if the integrity of an article is called into question, our policy is to investigate. Upon further scrutiny by our Research Integrity team about the objectivity of this paper during the provisional acceptance phase, it was revealed that the article made a series of strong, unsupported claims based on studies with insufficient statistical significance, and at times, without the use of control groups. Further, the authors promoted their own specific ivermectin-based treatment which is inappropriate for a review article and against our editorial policies.

https://blog.frontiersin.org/2021/03/02/...statement/

This might help you understand (maybe-click on the links in the article, read the responses): https://blogs.sciencemag.org/pipeline/ar...19-therapy

Or you could simply google 'latest covid ivermectin clinical trial results' and start reading.